SOLARA ACTIVE PHARMA SCIENCE Financial Statement Analysis
|
||
The Revenues of SOLARA ACTIVE PHARMA SCIENCE have increased by 13.83% YoY .
The Earnings Per Share (EPS) of SOLARA ACTIVE PHARMA SCIENCE has decreased by Negative YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
SOLARA ACTIVE PHARMA SCIENCE Last 5 Annual Financial Results
[BOM: 541540|NSE : SOLARA]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹1,444 Cr | ₹1,268 Cr | ₹1,617 Cr | ₹1,322 Cr | ₹1,409 Cr |
Expenses | ₹1,310 Cr | ₹1,188 Cr | ₹1,231 Cr | ₹1,062 Cr | ₹1,197 Cr |
Operating Profit (Excl OI) | ₹134 Cr | ₹80 Cr | ₹386 Cr | ₹259 Cr | ₹212 Cr |
Other Income | ₹23 Cr | ₹20 Cr | ₹29 Cr | ₹28 Cr | ₹12 Cr |
Interest | ₹90 Cr | ₹75 Cr | ₹84 Cr | ₹78 Cr | ₹82 Cr |
Depreciation | ₹111 Cr | ₹112 Cr | ₹109 Cr | ₹94 Cr | ₹84 Cr |
Profit Before Tax | ₹-45 Cr | ₹-91 Cr | ₹222 Cr | ₹115 Cr | ₹58 Cr |
Profit After Tax | ₹-22 Cr | ₹-58 Cr | ₹221 Cr | ₹115 Cr | ₹59 Cr |
Consolidated Net Profit | ₹-22 Cr | ₹-58 Cr | ₹221 Cr | ₹115 Cr | ₹60 Cr |
Earnings Per Share (Rs) | ₹-6.16 | ₹-16.15 | ₹61.62 | ₹42.69 | ₹23.09 |
PAT Margin (%) | -1.54 | -4.60 | 13.69 | 8.66 | 4.22 |
ROE(%) | -1.47 | -3.75 | 17.23 | 12.48 | 7.36 |
ROCE(%) | 1.79 | -0.67 | 15.34 | 11.73 | 9.70 |
Total Debt/Equity(x) | 0.67 | 0.67 | 0.38 | 0.72 | 0.63 |
Key Financials |
||
Market Cap | : | ₹ 1,340.8 Cr |
Revenue (TTM) | : | ₹ 1,406.9 Cr |
Net Profit(TTM) | : | ₹ -307.8 Cr |
EPS (TTM) | : | ₹ -85.5 |
P/E (TTM) | : | - |
Industry Peers & Returns | 1W | 1M | 1Y |
SOLARA ACTIVE PHARMA SCIENCE | 0.3% | -24.2% | 5.4% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
SOLARA ACTIVE PHARMA SCIENCE Revenues
[BOM: 541540|NSE : SOLARA]
Y-o-Y | 13.83 % |
5 Yr CAGR | 0.62 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹1,444 Cr | 13.83 | |
Mar2022 | ₹1,268 Cr | -21.56 | |
Mar2021 | ₹1,617 Cr | 22.33 | |
Mar2020 | ₹1,322 Cr | -6.16 | |
Mar2019 | ₹1,409 Cr | - |
SOLARA ACTIVE PHARMA SCIENCE Operating Profit
[BOM: 541540|NSE : SOLARA]
Y-o-Y | 67.41 % |
5 Yr CAGR | -10.81 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹134 Cr | 67.41 | |
Mar2022 | ₹80 Cr | -79.28 | |
Mar2021 | ₹386 Cr | 48.73 | |
Mar2020 | ₹259 Cr | 22.64 | |
Mar2019 | ₹212 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 46.91 % |
5 Yr CAGR | -11.37 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 9.27% | 46.91 | |
Mar2022 | 6.31% | -73.57 | |
Mar2021 | 23.87% | 21.60 | |
Mar2020 | 19.63% | 30.69 | |
Mar2019 | 15.02% | - |
SOLARA ACTIVE PHARMA SCIENCE Profit After Tax
[BOM: 541540|NSE : SOLARA]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹-22 Cr | Negative | |
Mar2022 | ₹-58 Cr | Negative | |
Mar2021 | ₹221 Cr | 93.18 | |
Mar2020 | ₹115 Cr | 92.59 | |
Mar2019 | ₹60 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | -1.54 % | Negative | |
Mar2022 | -4.6 % | Negative | |
Mar2021 | 13.69 % | 58.08 | |
Mar2020 | 8.66 % | 105.21 | |
Mar2019 | 4.22 % | - |
SOLARA ACTIVE PHARMA SCIENCE Earnings Per Share (EPS)
[BOM: 541540|NSE : SOLARA]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹-6.16 | Negative | |
Mar2022 | ₹-16 | Negative | |
Mar2021 | ₹62 | 44.34 | |
Mar2020 | ₹43 | 84.89 | |
Mar2019 | ₹23 | - |
SOLARA ACTIVE PHARMA SCIENCE Return on Capital Employed (ROCE)
[BOM: 541540|NSE : SOLARA]
Y-o-Y | Positive |
5 Yr CAGR | -34.46 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 1.79% | Positive | |
Mar2022 | -0.67% | Negative | |
Mar2021 | 15.34% | 30.78 | |
Mar2020 | 11.73% | 20.93 | |
Mar2019 | 9.7% | - |
SOLARA ACTIVE PHARMA SCIENCE Share Price vs Sensex
Current Share Price | : | ₹372.5 |
Current MarketCap | : | ₹ 1,340.8 Cr |
Updated EOD on | : | Mar 28,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SOLARA ACTIVE PHARMA SCIENCE | 0.3% |
-24.2% |
5.4% |
SENSEX | -0.4% |
-0.9% |
25.8% |
SOLARA ACTIVE PHARMA SCIENCE related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE MIDSMALLCAP | 1.9% | -4.4% | 61.2% |
S&P BSE SMALL CAP | 1.8% | -6.7% | 58.8% |
S&P BSE HEALTHCARE | 1% | -3.2% | 60.6% |
S&P BSE ALLCAP | 0.8% | -1.8% | 40.5% |
You may also like the below Video Courses
FAQ about SOLARA ACTIVE PHARMA SCIENCE Financials
How the annual revenues of SOLARA ACTIVE PHARMA SCIENCE have changed ?
The Revenues of SOLARA ACTIVE PHARMA SCIENCE have increased by 13.83% YoY .
How the Earnings per Share (EPS) of SOLARA ACTIVE PHARMA SCIENCE have changed?
The Earnings Per Share (EPS) of SOLARA ACTIVE PHARMA SCIENCE has decreased by Negative YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs